(3R)-1-[(benzyloxy)carbonyl]-3-hydroxy-D-proline | 1215291-99-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (3R)-1-[(benzyloxy)carbonyl]-3-hydroxy-D-proline
• 英文别名: (2R,3R)-1-[(benzyloxy)carbonyl]-3-hydroxypyrrolidine-2-carboxylic acid；trans-N-Benzyloxycarbonyl-3-hydroxyprolin；N-Z-trans-3-hydroxy-proline；(2R,3R)-3-hydroxy-1,2-Pyrrolidinedicarboxylic acid, 1-(phenylMethyl) ester；(2R,3R)-3-hydroxy-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid
• CAS: 1215291-99-8
• 化学式: C₁₃H₁₅NO₅
• 分子量: 265.266
• InChiKey: PXVPQILKAQMLKV-GHMZBOCLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  87.1
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (3R)-1-[(benzyloxy)carbonyl]-3-hydroxy-D-proline 在 盐酸 、 Amberlyst 15 作用下， 以 乙酸乙酯 为溶剂， 反应 1.0h， 生成 (2R,3R)-methyl 3-hydroxypyrrolidine-2-carboxylate
  参考文献：
  名称：

  2-取代的具有与氨基酸相关的侧链的Penems：新系列的β-内酰胺类抗生素的合成和抗菌活性。

  摘要：

  合成了一系列新的6-（羟乙基）青霉烯2-氨基酸相关的侧链取代。从合成的观点来看，氨基酰基衍生物的性质被证明是至关重要的，因为β-内酰胺开环可以与C-2亲核取代竞争，并且具有抗菌活性。伯氨基酸酰胺作为增强通过革兰氏阴性外膜渗透性的最合适的侧链出现。新的2-[（（氨基酰胺基）甲基]青霉烯3a-u）的体外活性受酰胺部分的性质和位置，环状酰胺的环大小以及氨基酸构型的影响。

  DOI：

  10.1021/jm00021a013
• 作为产物：
  描述：

  反式-3-羟基-D-脯氨酸 、 氯甲酸苄酯 在 碳酸氢钠 作用下， 以 四氢呋喃 、 水 为溶剂， 以1.72 g的产率得到(3R)-1-[(benzyloxy)carbonyl]-3-hydroxy-D-proline
  参考文献：
  名称：

  EP3643703

  摘要：

  公开号：

文献信息

• EP300/CREBBP INHIBITOR
  申请人：Daiichi Sankyo Co., Ltd.

  公开号：EP3643703A1

  公开（公告）日：2020-04-29

  The present invention provides a compound having excellent histone acetyltransferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein ring Q1, ring Q2, R1, R2, R3 and R4 respectively have the same meanings as defined in the specification.

  本发明提供了一种对 EP300 和/或 CREBBP 具有优异组蛋白乙酰转移酶抑制活性的化合物或其药理学上可接受的盐。该化合物由下式（1）或其药理学上可接受的盐表示： 其中，环 Q1、环 Q2、R1、R2、R3 和 R4 分别具有本说明书中定义的相同含义。
• EP3643703
  申请人：——

  公开号：——

  公开（公告）日：——
• THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF
  申请人：[en]VENTUS THERAPEUTICS U.S., INC.

  公开号：WO2024137607A1

  公开（公告）日：2024-06-27

  The present disclosure relates to compounds of Formula (I): (I) or a pharmaceutically acceptable salt thereof, wherein Ring A, R1, R2, R3, R4, and m are described herein, methods of preparation, methods of treatment, and pharmaceutical compositions comprising same. The present disclosure further relates to the use of the compounds of Formula (I), and pharmaceutically acceptable salts thereof, in the treatment of cGAS-related diseases and disorders.
• Synthesis and Evaluation of Lysophosphatidylserine Analogues as Inducers of Mast Cell Degranulation. Potent Activities of Lysophosphatidylthreonine and Its 2-Deoxy Derivative
  作者：Masazumi Iwashita、Kumiko Makide、Taro Nonomura、Yoshimasa Misumi、Yuko Otani、Mayuko Ishida、Ryo Taguchi、Masafumi Tsujimoto、Junken Aoki、Hiroyuki Arai、Tomohiko Ohwada

  DOI：10.1021/jm900598m

  日期：2009.10.8

  In response to various exogenous stimuli, mast cells (MCs) release a wide variety of inflammatory mediators stored in their cytoplasmic granules and this release initiates subsequent allergic reactions. Lysophosphatidylserine (lysoPS) has been known as an exogenous inducer to potentiate histamine release from MCs, though even at submicromolar concentrations. In this study, through SAR studies on lysoPS against MC degranulation, we identified lysoPT, a threonine-containing lysophospholipid and its 2-deoxy derivative as novel strong agonists. LysoPT and its 2-deoxy derivative induced histamine release from MCs both in vitro and in vivo at a concentration less than one-tenth that of lysoPS. Notably, lysoPT did not activate a recently proposed lysoPS receptor on MCs, GPR34, demonstrating the presence of another undefined receptor reactive to both lysoPS and lysoPT that is involved in MC degranulation. Thus, the present strong agonists, lysoPT and its 2-deoxy derivative, will be useful tools to understand the mechanisms of lysoPS-induced activation of degranulation of MCs.
• 2-Substituted Penems with Amino Acid-Related Side Chains: Synthesis and Antibacterial Activity of a New Series of .beta.-Lactam Antibiotics
  作者：Maria Altamura、Enzo Perrotta、Piero Sbraci、Vittorio Pestellini、Federico Arcamone、Giuseppe Cascio、Laura Lorenzi、Giuseppe Satta、Grazia Morandotti、Roberta Sperning

  DOI：10.1021/jm00021a013

  日期：1995.10

  A new series of 6-(hydroxyethyl)penems 2-substituted with amino acid-related side chains was synthesized. The nature of the amino acyl derivative proved to be crucial both from a synthetic point of view, as beta-lactam ring opening can compete with C-2 nucleophilic substitution, and for antibacterial activity. Primary amino acid amides emerged as the most suitable side chains for enhancing permeability

  合成了一系列新的6-（羟乙基）青霉烯2-氨基酸相关的侧链取代。从合成的观点来看，氨基酰基衍生物的性质被证明是至关重要的，因为β-内酰胺开环可以与C-2亲核取代竞争，并且具有抗菌活性。伯氨基酸酰胺作为增强通过革兰氏阴性外膜渗透性的最合适的侧链出现。新的2-[（（氨基酰胺基）甲基]青霉烯3a-u）的体外活性受酰胺部分的性质和位置，环状酰胺的环大小以及氨基酸构型的影响。